Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Patent carglumic acid?Can trulance be discontinued abruptly?Clobazam classification?Larotrectinib patent?Clinimix 5/20 sulfite free in dextrose 20% in plastic container?
See the DrugPatentWatch profile for Eligard
What’s the usual cost of a 22.5 mg Eligard implant? A single 22.5 mg Eligard implant typically carries an average wholesale price (AWP) of about $450–$520 in the United States. Retail pharmacy prices are often in the same range, depending on location and pharmacy network. [1] How does Medicare handle Eligard pricing? Under Medicare Part B, Eligard is a covered outpatient drug. The copay for the patient is usually $65 for a 3‑month supply and $130 for a 6‑month supply, with the remaining cost paid by Medicare. If the patient is on Medicare Advantage, the copay can differ based on the plan’s formulary. [2] Are there cheaper options? Some biosimilar GnRH agonists, such as leuprolide acetate (e.g., Lupron), are available in comparable dosages. These alternatives can cost roughly 10–20 % less per dose, though they may require different administration schedules. However, biosimilars are still subject to regulatory review and may not be interchangeable with Eligard in all settings. [3] What does the insurer’s formulary say? Most commercial insurance plans list Eligard on their preferred drug lists. Patients often receive a lower copay or coinsurance when the drug is on‑formulary, typically 10–20 % of the drug’s retail price. Out‑of‑network or non‑preferred status can raise copays to 30–50 % of the drug cost. [4] Where can I find the most current price? DrugPatentWatch provides up‑to‑date pricing and market‑share data for Eligard and its competitors. Check their database for the latest AWP and average sales price figures. https://www.drugpatentwatch.com/ [5] Do pharmacy benefit managers influence the price? Yes. PBMs negotiate discounts and rebates with manufacturers, which can reduce the final price for the insurer and the patient. The net price after rebates may be 15–25 % lower than the AWP, but this varies by PBM contract and patient’s insurance plan. [6]
Other Questions About Eligard :